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Why was the cohort set up?
Research on malnutrition and malaria has been conducted
in the Kiang West district of The Gambia (West Africa)
since 1950, initially through Professor Sir Ian McGregor’s
annual anthropometric and health surveys of the rural sub-
sistence farming community in this low- and middle-income
country (LMIC) setting (described in more detail else-
where1). With the establishment of a permanent field station
by the UK Medical Research Council (MRC Keneba) in
1974, research and health provision expanded into the
wider community. MRC Keneba is located in the heart of
the 750-km2 district located in the Lower River Region,
which until 2014 had limited road access (Figure 1).
Research facilities in KW were initially set up to support
nutrition studies, in particular for longitudinal studies of
growth in four ‘core villages’ (with 4000 residents).
Since 1989, research studies also recruited participants
from the wider district. The establishment of the com-
prehensive demographic surveillance [Kiang West
Demographic Surveillance System (KWDSS)], electronic
medical record [Keneba Electronic Medical Records
System (KEMReS)] and biobanking platforms (Keneba
Biobank) now comprises an integrated system for re-
search and health care provision to the whole of the
Kiang West Longitudinal Population Study (KWLPS) co-
hort (N14 000 across 36 villages).
Since 1949, this work has primarily been supported by
funds from the UK Medical Research Council (MRC) and
the UK Department for International Development (DFID)
under the MRC/DFID Concordat agreement.
Who is in the cohort?
The population of Kiang West is predominantly of
Mandinka ethnicity (Mandinka 79.9%, Fula 16.2%, Jola
VC The Author 2015. Published by Oxford University Press on behalf of the International Epidemiological Association 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-
nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way,
and that the work properly cited. For commercial re-use, please contact journals.permissions@oup.com
International Journal of Epidemiology, 2017, e13(1–12)
doi: 10.1093/ije/dyv206
Advance Access Publication Date: 11 November 2015
Cohort Profile
2.4%, other 1.3%) living across some 36 villages. Villages
are divided into compounds, where extended multi-gener-
ational families live together with an average of 16 people
per compound (range 1–170). This predominantly Muslim
society practises polygamy. Rural subsistence farming is
the main livelihood. Income and eating patterns fluctuate
strongly according to the annual farming calendar, heavily
influenced by the annual rainy season (June to October).
Although more than half of the Gambian adult population
has not received any education, with higher proportions in
rural areas, the gross enrolment ratios for lower basic (ages
7–12 years) and upper basic (ages 13–15 years) education
are around 88% and 66%, respectively, with an increase
in the number of girls attending school over the years; ap-
proximately half of the children not in lower basic educa-
tion attend Islamic schooling.2,3
The ‘core’ villages of Keneba, Manduar, Kantong Kunda
and for a limited period Jali, have been the subject of longitu-
dinal demographic and health surveys since 1950. In 1974
and 1977 respectively, regular outpatient and antenatal clin-
ics were established at the MRC Keneba field station to serve
the medical needs of these villages. Health care provision
and research studies after 1989 started to extend beyond the
core villages in the wider Kiang West District (Figure 2).
Figure 1. Map of the study area. The Kiang West district is located in the lower river division in The Gambia. Initial surveys were conducted in the
core villages—Keneba, Manduar, KantongKunda and Jali (dark grey circles). The MRC Keneba field station now serves all villages in the district (light
grey circles) captured by the KW Demographic Surveillance System (KWDSS). There are also two small government health centres (squares labelled
M). A midwife is stationed in Jiffarong and the nearest hospital is in Bwiam (square labelled H) outside the district on the main road to the coast, re-
spectively (for more details see Supplementary materials, available as Supplementary data at IJE online).
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Since 2004, all Kiang West residents are captured by the
KWDSS; this now forms the backbone of the data flow struc-
ture and participant recruitment for all MRC research stud-
ies in the region (Figure 3). In 2009, the KEMReS was
launched to capture detailed morbidity data of Kiang West
citizens for all primary health care contacts with the clinic at
MRC Keneba. The Keneba Biobank was established in
2012. All recent and ongoing research projects are linked to
one or more elements of the platforms triad KWDSS/
KEMReS/KenebaBiobank. Data capture using electronic tab-
lets has been introduced for our most recent studies in the re-
gion. Study-specific databases are not described here in
detail, but we refer the reader to the references in the findings
section below and our publication list via the MRC ING
website [www.ing.mrc.ac.uk]. However, information on lon-
gitudinal databases (i.e. core village and other longitudinal
data), as well as systematically collected data, is given in the
following sections. Summary statistics for the KWLPS cohort
are shown in Table 1 and also in Supplementary Figure 1
(available as Supplementary data at IJE online).
How often have they been followed up?
Core village and historical data
The conduct and content of demographic and health sur-
veys, clinics and vaccination programmes before 2004, as
well as the resulting reduction in mortality, have been
described in detail by Rayco-Solon and colleagues.1
Medical data at the MRC Keneba clinic were collected on
paper before 2009. Data of structured child welfare clinics,
vaccinations and antenatal clinics were entered into a data-
base for those residing in the core villages since around
2000 (Figure 2). The remainder of medical data recordings
for Kiang West residents beyond the core villages was not
electronically transcribed before 2009.
KWDSS
The main purpose of the KWDSS is to provide reliable and
up-to-date demographic data on the population of the
Kiang West, to support the many research projects con-
ducted by the MRC in the district. In particular it provides:
i. a common numbering system for all Kiang West resi-
dents and study subjects;
ii. accurate dates of birth and identification of parents;
iii. a sampling frame for study participant selection;
iv. population structure, used to facilitate the design/as-
sess feasibility of new studies;
v. residence histories for survival analyses;
vi. and tracking of individuals’ movements, to facilitate
longitudinal and follow-up studies.
Figure 2. Schematic representation of time lines of data collection in Kiang West. Studies and surveys, especially those since 2000, are contained
within the Kiang West Longitudinal Population Study (KWLPS) electronic databases.
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Figure 3. Database structure and data flow for the Kiang West Longitudinal Population Study (KWLPS) cohort. For further details on the KWLPS data-
bases see Supplementary materials (available as Supplementary data at IJE online).
Table 1. Summary statistics of the Kiang West Longitudinal Population Study (KWLPS) cohort in
2013 and of The Gambia national data in comparison
Parameter Kiang West The Gambia Unit
Total population 14 846 1 967 7092 Inhabitants
Crude birth rate 34.86 30.062 Births per 1000 people
Total fertility rate 5.50 3.732 Babies per lifetime
Crude death rate 6.40 7.172 Per 1000 people
Neonatal mortality rate 23.44 223 Per 1000 births
Post-neonatal mortality rate 15.63 123 Per 1000 births
Infant mortality rate (aged<1 year) 39 343 Per 1000 live births
Child mortality rate (1–4 years) 6 203 Per 1000 live 1-year-olds
Under-five mortality (< 5 years) 45 543 Per 1000 live births
Crude rate of natural increase 28.46 24.49 Per 1000 people (birth rate
minus crude death rate)
In-migration rate 89.86 N/A Per 1000 people
Out-migration rate 88.91 N/A Per 1000 people
Life expectancy at birth, female 73.46 (64.94, 81.98) 63 (N/S)12 Years (CI 95%)
Life expectancy at birth, male 65.28 (58.71, 71.84) 59 (N/S)12 Years (CI 95%)
N/A, not applicable; N/S, not specified.
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Every individual who has been resident in Kiang West
since 2004, and all who have taken part in our studies be-
fore that date, are assigned a unique identity number
(ID), the West Kiang number (WKNO). Every compound
in the district is visited once every 3 months according to
a fixed schedule. The first 2 months of each cycle are
dedicated to routine visits and the third is set aside to re-
solve discrepancies and double registrations and link the
unique ID of the parents of newly registered individuals,
linking district-internal migration movements and con-
duct quality assurance. At each visit a senior member of
the compound is interviewed to provide the required
information.
Since the KWDSS is used as a sampling frame within
the KWLPS cohort, maintaining the integrity of the link-
ages within the KWDSS, and between it and other data-
bases, is critical. In order to achieve this, we impose two
basic constraints: (i) no individual can be recruited by a
study or the clinic until they have been assigned a unique
ID number; and (ii) no delivery can be recorded in the ma-
ternity database unless the mother has an ‘open’ pregnancy
episode recorded. It is also often necessary to find the
unique ID number of an individual based on limited infor-
mation, but this is not always a straightforward task in a
setting such as rural Gambia. For this purpose we devised
a search utility, the ‘Demography Search using Bayes’
(DSUB) algorithm to search the KWDSS database for indi-
vidual(s). The user may input whatever is known of the in-
dividual and the programme outputs the best matches. The
KWDSS is a registered INDEPTH Network [http://www.
indepth-network.org/] member centre. Additional informa-
tion on the KWDSS, including the search algorithm, is
given in the Supplementary materials (available as
Supplementary data at IJE online).
KEMReS
The primary health care clinic at the MRC Keneba field
station (Figure 1) provides general health care to all Kiang
West citizens who present with acute or chronic medical
conditions. Around 1500 patients, excluding visitors to
Kiang West, are seen each month, with seasonal variation
(Supplementary Figure 2, available as Supplementary data
at IJE online). Children aged under 5 years attend the
clinic in Keneba about four times per year, depending on
the village of origin within the district and transport avail-
ability. Emergency presentations are seen 24 h per day.
General, child welfare, antenatal/postnatal and non-commu-
nicable disease (NCD) clinics are run weekly. An observa-
tion room allows stabilization of patients, but full inpatient
facilities are not available. Patients requiring treatment at a
secondary/tertiary medical facility get transported to either
the clinic at MRC Fajara or the Edward Francis Small
Teaching Hospital (formerly the Royal Victoria Teaching
Hospital) in Banjul, both 2–3 h by road.
KEMReS started recording patient attendances in
December 2009 and was designed to capture clinical data
of all presentations at the clinic at MRC Keneba across all
age groups, to: understand in depth the epidemiology of
communicable and non-communicable diseases; support
ongoing research projects; and improve clinical care for the
population. The database also incorporates data on regular
child welfare clinics (for those aged<2 years) and vaccin-
ations. Electronic capture of antenatal/postnatal informa-
tion was added to KEMReS in 2013. KEMReS as a
platform in conjunction with the other databases can pro-
vide details on adverse events and/or morbidity data as
outcome measures for clinical trials in the district. For
more detail on the KEMReS set-up access, see
Supplementary materials (available as Supplementary data
at IJE online).
Keneba Biobank
The Keneba Biobank was initiated in May 2012, as a plat-
form for genetic studies and the collection of biological
samples and simple phenotypic measures for all consenting
individuals captured by the KWDSS. A custom-designed
database and sample tracking system was introduced,
which is used for all Biobank-related processes. The
Keneba Biobank is currently in its first round, with recruit-
ment standing at> 9000 participants to date. To ensure an
even distribution of recruitment by season, the region was
block randomized into 10 sectors of roughly equal size
comprising either a single village or several smaller vil-
lages. Every 2 weeks, recruitment moves to a different sec-
tor, with all sampling and most measures conducted in the
field. Participants are visited in the early morning to obtain
age group-specific data and (fasted) biological samples.
Clinical referral criteria were defined to identify urgent re-
ferrals (malaria or severe high blood pressure) observed
during the field visit. Affected participants, as well as those
who report feeling sick, are brought back to the MRC
Keneba clinic on the same day for evaluation by a clinician.
Non-urgent referrals (high glucose level, high blood pres-
sure, anaemia) are identified via a search function within
the Keneba Biobank database, and cases are called within
a few days for re-testing and clinical evaluation during
regular clinics (e.g. the weekly NCD clinic).
The Keneba Biobank is part of the LMIC Biobank and
Cohort Network (BCNet), [http://bcnet.iarc.fr/].4
Additional information on the Keneba Biobank is given in
the Supplementary materials (available as Supplementary
data at IJE online).
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What has been measured?
Core village and historical data
The KWLPS database comprises computerized records of
all Kiang West residents (N 14 000). For core village resi-
dents (N 4000) these date back to 1950,1 representing
life-course longitudinal nutritional and health phenotypes,
particularly relating to anthropometry/growth and mater-
nal health. The consistent and longitudinal recording of
the following measures were introduced over time.
• Since 1949: exact date of birth and parents’ IDs.
• Since 1980: birth (weight, length, gestational age, deliv-
ery date); growth (weight, height, mid upper-arm cir-
cumference, head circumference) for children on up to
12 occasions before 2 years of age and less frequently
thereafter); demographics (parents’ IDs), pregnancy out-
comes and reproductive histories; records of self-referrals
to clinic; and outcome measures from numerous specific
studies.
• Since 1990: most studies include anthropometric meas-
urements, blood pressure, dietary and lifestyle informa-
tion and blood and urine samples. In selected study
groups, detailed data on bone mineral content and dens-
ity, bone dimensions and more recently bone age, and
muscle force and power have been measured.
• Since 1996: vaccinations.
Please note that details of study databases are not
described here; further information can be found in the
findings section below and via the MRC ING publication
list [www.ing.mrc.ac.uk].
KWDSS
During each KWDSS round, the following information is
captured: migration movements, into and out of the com-
pound (both internal and external, including contact de-
tails for those leaving the district), births and deaths,
pregnancies (to avoid missing infants who die during the
neonatal period), marriages and the names or unique IDs
of the parents of all newborns or new arrivals. Details of
husbands of married women are mostly recorded to iden-
tify the children’s fathers. All changes in status for each
Kiang West citizen are captured.
An important feature of the KWDSS is that we allow
data to be recorded from other sources. For instance, births
and pregnancies may be derived from the maternity arm of
KEMReS. Similarly, information is rectified when patients
present to the general MRC Keneba clinic. This ensures
that dates of birth are recorded accurately and up-to-date
data on individuals are available from a single database
table without needing to wait for the next KWDSS round.
The two main types of data tables used by KWDSS are
‘constant’ and ‘episode’ (for details see Supplementary ma-
terials, available as Supplementary data at IJE online).
Briefly, constant tables are mostly used to record unchan-
ging data such as name or date of birth. Episode tables re-
cord details of time intervals, e.g. the residency of an
individual living in a particular compound.
KEMReS
KEMReS records a set of data entry fields for each stage
during a patient encounter based on well-known clinical
examination routines [Supplementary Figure 3 (available
as Supplementary data at IJE online) and Table 25].
Recorded information includes data on anthropometry,
vital signs, symptom history and examination findings, la-
boratory investigations, diagnoses and prescriptions pro-
vided. Data are stored with two specified ranges according
to age: (i) normal range; and (ii) possible range. An alert
for the clinician/nurse appears for values out of the normal
range, to address the finding clinically. A full data set at
each stage needs to be entered before the patient can pro-
ceed. This ensures the accuracy and completeness of data
collected at each clinic visit.
Past encounters and medical history are stored and
updated with each patient encounter to aid clinical assess-
ments and medical decisions. Diagnoses are recorded using
the WHO ICD-10 coding system.6 Diagnoses also include:
‘Well with a complaint’; ‘Well without a complaint’; and
‘Unknown diagnosis’. A free text entry can be used to de-
scribe possible diagnoses further. KEMReS is not a clinical
decision support system, although this can relatively easily
be added. However, KEMReS consists of a number of user
interfaces with several functionalities including clinical
care reports, referral letters, management reports and
medication dispensary reports. Furthermore, alerts are set
for due vaccinations and drug prescriptions, to be in line
with international guidelines on patient management7.
Keneba Biobank
Table 3 shows a summary of data and samples collected as
part of the Keneba Biobank by trained staff using standar-
dized operating procedures. Briefly, agegroup-specific data
and samples collected comprise: biological samples (ven-
ous blood, urine); questionnaire; anthropometry, body
composition based on bioelectrical impedance (using popu-
lation-specific equations8); and blood pressure. Biological
sample processing and a limited number of analytical tests
are conducted on fresh specimens at the MRC Keneba field
station. Analytical tests conducted comprise fasting glu-
cose, malaria, zinc protoporphyrin (discontinued in 2014)
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Table 2. Data collected in the Keneba Electronic Medical Records System (KEMReS) during each patient encounter
Data collection stage General description of data stored
Reception • Demographic data retrieved from KWDSS on arrival and updated if required
• Type of clinic visit (emergency, self-referred, follow-up, child welfare clinic, antenatal, research)
Triage • Anthropometry data after double entry by trained staff:
 Weight (all ages)
 Height/length (once above 25 years)
 Head circumference (HC) (< 3 years)
 Skinfold thickness (SFT) (all ages)
 MUAC (< 5 years)
• Vital signs and triage assessment data:
 Blood pressure, heart rate, respiratory rate, temperature, oxygen saturation
 Glasgow coma score
 WHO emergency signs (tick-boxes)
5
 WHO priority signs (tick-boxes)
5
Clinical triage (emergency/priority/routine)
Doctor/nurse • Vaccination record data (either given in the clinic or from infant welfare care)
• Details of past medical history:
 All previous clinic visits since start of KEMRES
 All known medical conditions of importance
 Birth history, drug history, drug allergy history, family history
 Status of breastfeeding (for all women aged 14-50 years)
• Present complaints (tick boxes for all systems) plus free text for additional information
• Physical examination details (combination of drop-down lists and tick-boxes for each body system);
free text available for any further comments
• Requested investigations—linked to laboratory
• Diagnosis with associated ICD-10 code;9 free text for specification or if diagnosis not available; tick-
boxes for ‘Well with complaint’, ‘Well without complaint’ or ‘Routine child health examination’
• Drug prescriptions: alerts for drugs presented; drug doses, frequencies and durations recorded and set
according to British National Formulary (BNF) guidelines.10 Restrictions for particular drugs for cer-
tain patient groups, e.g. aspirin not available for children under 12 years
• Information on suggested discharge from clinic and follow-up:
 None
 Admission to observation room
 Admission to nutritional rehabilitation centre
 Referral for secondary/tertiary care
• Information on planned review
• Option for referral letter print-out
Midwives • Obstetric history (including date of last menstrual period, previous pregnancies and modes of delivery)
• Antenatal clinic visit (including fundal height measurements)
• Delivery (including place, mode and time between rupture of membranes and start of labour)
• Baby check (including congenital abnormalities, gestational age based on Dubowizc)
• Postnatal (including any post-partum bleeding)
Laboratory • Details of all investigations available at MRC Keneba: blood film (thick/thin), blood glucose, sickle
test, HIV test, HcG, VDRL, blood group, sputum acid-fast bacilli (AFB), full blood count (FBC), blood
culture (children only), urine analysis, stool examination; free text for additional information
Dispensary • Check doctor’s prescription
• No data entry apart from a record of drugs actually issued
Check-out • No data entry
• Check whether all stages have been completed and investigations done and reviewed
• No check-out possible if clinic visit incomplete
• Paper check-out printed for filing
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and full blood count. Samples processing involves the
separation of blood fractions (serum, plasma, washed
red blood cells), treatment of urine and DNA extraction;
all samples are split into several aliquots and stored in
2D-barcoded microtubes at 70C within 2–4 h of
collection.
Ethical considerations
All studies and data collections in Kiang West are pre-
sented to and approved by the MRC Unit The Gambia
Scientific Committee (SCC) and joint Gambian
Government/MRC Unit The Gambia Ethics committee,
which is overseen by the ethics board of the London
School of Hygiene and Tropical Medicine (LSHTM). For
research studies, all participants and/or legal guardians
provide written, informed consent.
What has it found? Key findings and
publications
Summary statistics of the KWLPS cohort compared with
national data from The Gambia are shown in Table 1. It is
noteworthy that mortality rates have improved dramatic-
ally over the past decades,1 with higher life expectancy in
women and greater reductions in crude and child mortality
rates seen in Kiang West than elsewhere in The Gambia.2,9
Differences are likely due to higher standards of clinical
services children and women receive, including regular
child welfare clinics and ante- and postnatal follow-up in
Kiang West, compared with other regions. Slightly
higher neonatal, post-neonatal and infant mortality rates
in Kiang West compared with national data probably re-
late to the better capture of data on deaths, since almost
all pregnancies are monitored and their outcomes re-
corded. Table 4 shows the 10 most common medical
diagnoses by age group based on ICD-10 coding.6
Morbidity patterns are similar to previous studies in the
sub-region, with around 30% related to respiratory ill-
ness.10 In those over 50 years old, NCDs form a large
part of clinic presentations. Prevalence of malaria across
the whole of the Gambian population has decreased re-
cently11 and, particularly in those under 10 years of age,
malaria represents now fewer than 2% of all clinic
presentations.
There are numerous publications describing the vast
body of research conducted in the KWLPS cohort since the
early 1950s, too many to list and describe. However, the
key findings and publications can be broadly described
under the categories of: (i) secular trends; (ii) major re-
search findings; and (iii) recent developments. A short sum-
mary of these is given below; for a comprehensive list of
references over recent years, see our publication list via the
MRC ING website [www.ing.mrc.ac.uk].
i. Reports on secular trends describe declining mortality
trends;1,12,13 intergenerational and demographic tran-
sition effects on growth14,15 and survival;16 reductions
in diarrhoea rates;17 declining malaria rates.11
ii. Major research findings include: insights into season of
birth or conception effects on mortality;18 immune
outcomes19 and DNA methylation;20 effects of preg-
nancy supplementation on low birthweight;21
Table 3. Data and samples collected as part of the Keneba Biobank
< 5-year-olds 5–18 year olds 18-year-olds
Questionnaire N/A N/A Education, assets, medication for
diabetes and hypertension
received outside the district
Phenotypes Weight, height, skinfold thick-
ness, head circumference, mid
upper-arm circumference
Weight, height, body compos-
ition, blood pressure
Weight, height, body compos-
ition, blood pressure
Field and laboratory analyses Malaria test, ZNPP, full blood
count
ZNPP, glucose, blood pressure,
full blood count
ZNPP, glucose, blood pressure,
full blood count
Biological samples collected Unfasted blood (4.0 ml EDTA,
1.2 ml serum)
Fasted blood (4.9 ml EDTA,
1.2 ml LH, 4.5 ml serum)
and3 ml urine
Fasted blood (4.9 ml EDTA,
1.2 ml LH, 4.5 ml serum)
and3 ml urine
Biological sample aliquots
banked
Whole blood, red blood cells,
plasma, serum, DNA
Whole blood, red blood cells,
plasma, serum, DNA; urine
(spun, unspun, acidified)
Whole blood, red blood cells,
plasma, serum, DNA, urine
(spun, unspun, acidified)
Weight in kg to the nearest 10 g; height, head circumference and mid upper-arm circumference (MUAC) to the nearest 0.1 cm; body composition by Tanita BC-
418 MA analyser; blood pressure Omron 705-CPII; fasting glucose Accu Check (Roche Diagnostics); malaria rapid test (Standard Diagnostics); zinc protopor-
phyrin (ZnPP) by haematoflurometer (Aviv Biomedical); full blood count by Medonic M-series 3-part haematology analyser (Boule Medical); acidified urine sam-
ples treated with concentrated hydrogen chloride; EDTA, ethylenediaminetetraacetic acid; LH, lithium-heparin.
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increased understanding of growth faltering; identifica-
tion of critical windows beyond the ‘first 1000 days’
for possible nutritional interventions to address
stunting;22 lack of anticipated benefits of calcium sup-
plementation in children and pregnant mothers with a
very low calcium intake, with identification of
unexpected, possibly adverse, long-term skeletal ef-
fects;23–25 the use of MUAC to identify infants at
increased risk of death in LMIC;26 and the efficacy of
hepatitis B vaccination after 24 years of follow-up.27
iii. More recent developments with respect to the KWLPS
cohort are covered by the following publications on:
early nutrition and immune development via a birth
cohort followed up since 2010 (the ENID trial);28 life
course nutrition and health, including immune/inflam-
matory outcomes29 and cognitive development;30 the
role of the iron-hepcidin axis in infection;31,32 and sea-
sonal effects on blood cell composition.33
What are the main strengths and
weaknesses?
Strengths
• Stable, well-characterized and ‘research-friendly’ popula-
tion in rural sub-Saharan Africa of highly homogeneous
ethnicity. Exceptional long-term relationship between
population and MRC maintained through high levels of
communication between MRC staff and villages and
with great care taken to ensure research ethics.
• Computerized records of all Kiang West residents, some
of which date back to 1950, representing a unique level
of life-course nutritional and health phenotypes includ-
ing: birth anthropometry and details of mother’s health
and nutritional status in pregnancy; detailed serial post-
natal anthropometry; active health surveillance at child
welfare clinics from from birth to 24 months; records of
self-referrals to clinic thereafter; reproductive histories;
and outcome measures from numerous specific studies.
• A setting that facilitates research on the complex rela-
tionships between diet, health and survival in an environ-
ment where infectious diseases still play a major role in
mediating population health, e.g. seasonal influences.
• Integrated demographic surveillance and clinical and
biobank research platforms with standardized variable
measurements using a unique identification number per
person.
• Detailed pedigree records facilitating research across
multiple generations.
• Custom-designed framework for KWDSS, KEMReS and
Keneba Biobank databases with: user-friendly interface
for use by low-information technology (IT)-skilled health
professionals, laboratory and field staff; coded data ra-
ther than free text; and lists facilitating ease of data man-
agement, with clear patient/participant flow limiting
missing data.
• Automated processes including the generation of consent
and call lists; collection and logging of participant infor-
mation on basic demographics, phenotypes and labora-
tory tests; collection, logging and tracking logging of
biological samples.
• The majority of research platforms and ongoing studies
now work on the basis of live/current direct data entry,
thereby reducing the possibility of data errors.
• Large repository of banked biological samples.
• Established procedure for access to samples and data via
KDSG and SCC/EC application (see below).
• Good database and IT support.
Weaknesses
• The size of the total population of Kiang West
(N 14000) is limiting for the study of, for example,
rare diseases, diseases occurring infrequently in this
population or in sub-groups such as women who have
never been pregnant, and there is a risk of ‘over
studying’.
• The KWDSS system yields useful background data on
the demographic status and changes in the area, although
the population size is insufficient for some aspects of
demographic research.
• The majority of longitudinal data are restricted to resi-
dents of the core villages (N 4000), with Kiang West-
wide (N 14000) data collections being more recent.
• There is some bias regarding the age-sex distribution be-
tween the ages of 20 and 50, due to (temporary) out-
migration to urban areas for work (see Supplementary
Figure 1, available as Supplementary data at IJE online).
However, we increasingly conduct studies and follow-
ups outside the district.
• Although the mortality overall in the Kiang West district
is lower than the country average, the morbidity profile
is comparable across The Gambia (see Tables 1 and 3).9
Can I get hold of the data? Where can I find
out more?
Access permission for collaborators is regulated via one or
more of the following: the principal investigator of plat-
forms/research studies; the head of MRC KenebaField
Station; or head of MRC ING. Further details can be found
via the MRC International Nutrition Group website
[www.ing.mrc.ac.uk]. Access is controlled via the Keneba
10 International Journal of Epidemiology, 2017, Vol. 46, No. 2
Database Steering Group (KDSG) and/or applications to
joint the Gambia Government/MRC Ethics Committee
(SCC/EC).
Supplementary Data
Supplementary data are available at IJE online.
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